Baird Capital Portfolio Company OncoHealth Announces New Strategic Investments

Baird Capital

Baird Capital portfolio company OncoHealth, a leading digital health company dedicated to oncology, today announced new strategic investments from Arsenal Capital Partners (“Arsenal”) and McKesson Corporation (“McKesson”). Arsenal will take a majority ownership stake in the business and Baird Capital will retain a minority equity stake in the business; additional financial terms of the transaction were not disclosed.

Baird Capital initially invested in OncoHealth in May 2020 when the Venture team led a $28 million, Series C financing round. The new investments from Arsenal and McKesson will continue to support OncoHealth’s innovation and delivery of its oncology-specific digital health solutions for people with cancer.

Categories: News

Tags:

Oakley partners with the founders of digitally native golf brand

Oakley
  • Premium golf balls sold direct-to-consumer offers competitive pricing advantage
  • Innovative design and focus on social media provide marketing edge
  • Large, stable golf market benefitting from a shift to healthy living and flexible working

Oakley Capital, the pan-European private equity investor, is pleased to announce that Oakley Capital Origin Fund is investing in Vice Sporting Goods GmbH (“Vice Golf”), the leading digitally native golf brand.

Golf is a centuries-old sport that has proven its enduring appeal and stability through economic cycles and is today played by c.70 million across the globe. It has seen a significant boost during the COVID pandemic with the number of golf rounds played in the US increasing 20% between 2019 and 2021, driven by existing players playing more rounds and new players embracing the sport, as well as a shift to healthy living and flexible working.

Founded in 2012 in Munich by entrepreneurs Ingo Düllmann and Rainer Stöckl, Vice Golf has a strong track record of profitable growth with >40% top-line CAGR between FY18 and FY21 at ~20% EBITDA margin. The Company has successfully disrupted the golf ball market by offering premium golf balls at significantly lower price points than comparable products through its direct-to-consumer (DTC) business model and social media marketing.

Vice Golf has developed an enthusiastic following and established itself as the largest digital-first player in the global golf ball market thanks to its product proposition and novel designs. The Company principally sells golf balls as well as accessories such as caps and gloves to golfers of all ages and skill levels across the US and Europe. Following customer demand Vice Golf recently entered the apparel segment via highly successfully collaborations with top brands such as Adidas and Beastin.

Oakley’s partnership with Vice Golf builds on the firm’s deep expertise supporting DTC businesses such as Gymondo (part of 7NXT), Germany’s leading online fitness and nutrition platform, and Wishcard, one of Europe’s leading digital gift card companies. The investment in Vice Golf is another example of Oakley’s ability to leverage its wider network and reputation to form long-lasting partnerships with successful entrepreneurs. Oakley’s investment will help the business to accelerate its growth, product diversification strategy and internationalisation.

Oakley Capital Founder and Managing Partner, Peter Dubens, commented: 

“Vice Golf has seen impressive growth thanks to its innovative approach of offering passionate golfers leading product quality at a highly competitive price. We look forward to working with Ingo and Rainer and helping the Vice Golf team to build a globally leading multi-product brand in the golf world.”

Oakley Capital

We were attracted to Oakley’s successful record of partnering with disruptive brands and founders. And as business founders, Oakley’s entrepreneurial heritage particularly appealed to us. With their support, we are confident that we can further accelerate our ambitious growth strategy for Vice Golf.
Ingo Düllmann and Rainer Stöckl
Vice Golf Co-Founders

Categories: News

Tags:

New revolving credit facility of CHF 250 million for Swiss Medical Network SA

Aevis Victoria

AEVIS VICTORIA SA / Key word(s): Miscellaneous

06-May-2022 / 07:00 CET/CEST

Release of an ad hoc announcement pursuant to Art. 53 LR

The issuer is solely responsible for the content of this announcement.


Ad hoc announcement pursuant to Art. 53 LR

Fribourg, 6 May 2022

AEVIS VICTORIA SA: New revolving credit facility of CHF 250 million for Swiss Medical Network SA

Swiss Medical Network SA, the second largest private hospital and clinic group in Switzerland and the largest subsidiary of AEVIS VICTORIA SA, signed a new CHF 250 million revolving credit facility provided by a Swiss banking syndicate led by Credit Suisse (Schweiz) AG. This credit facility replaces the existing CHF 120 million revolving credit line implemented in 2017.

The five-year credit facility is made available to the hospital network for general business purposes and future acquisitions. Thanks to the improved maturity level of Swiss Medical Network, the new revolving credit facility provides more advantageous terms and covenants as well as increased flexibility to the group.

For further information:
AEVIS VICTORIA SA Media and Investor Relations: c/o Dynamics Group, Zurich
Philippe R. Blangey, prb@dynamicsgroup.ch, +41 (0) 43 268 32 35 or +41 (0) 79 785 46 32
Séverine Van der Schueren, svanderschueren@aevis.com, +41 (0) 79 635 04 10

AEVIS VICTORIA SA – Investing for a better life
AEVIS VICTORIA SA invests in healthcare, hospitality & lifestyle and infrastructure. AEVIS′s main shareholdings are Swiss Medical Network SA (90%, directly and indirectly), the only Swiss private network of hospitals present in the country’s three main language regions, Victoria-Jungfrau AG, a luxury hotel group managing ten luxury hotels in Switzerland and abroad, Infracore SA (30%, directly and indirectly), a real estate company dedicated to healthcare-related infrastructure, Swiss Hotel Properties SA, a hospitality real estate division, and NESCENS SA, a brand dedicated to better aging. AEVIS is listed on the Swiss Reporting Standard of the SIX Swiss Exchange (AEVS.SW). www.aevis.com.

 

Additional features:

File: AEVIS VICTORIA SA: New revolving credit facility of CHF 250 million for Swiss Medical Network SA


End of ad hoc announcement

Categories: News

Tags:

Navamedic acquires Impolin AB and broadens obesity portfolio

Reiten

Navamedic announced on Thursday 5th of May that it has entered into a share purchase agreement with Agnvicen AB to acquire 100% of the shares in Impolin AB for a purchase price of SEK 50 mill on a debt and cash free basis. The acquisition strengthens Navamedic’s position in the market for obesity treatment, enabling them to support patients and consumers during weight loss or obesity treatment.

Impolin AB is a Stockholm based company that specializes in products related to the pre- and post-treatment for bariatric surgery. Impolin’s portfolio includes Modifast, a range of diet and meal replacement products, and MedMade, a multivitamin and minerals tablet for post-bariatric surgery supplementation, which are products aimed at supporting patients during weight loss or obesity treatment, including bariatric surgery. Navamedic’s addition of Modifast and MedMade is set to broaden their current product offering within the area of obesity treatment, which enables the company to support patients throughout the entire weight loss journey.

“Our ambitions are bold, but by capitalizing on the strong transaction synergies, I am confident that we will successfully launch our expanded product range across the Nordic territory. Together with the Impolin team, we are planning to launch Modifast in Norway in 2023, followed by rollout in Finland and Denmark, and double product revenue by the end of 2028,” commented Kathrine Gamborg Andreassen, CEO of Navamedic.

“Navamedic has dedicated part of its product portfolio to treating obesity, making the company our preferred partner. With Navamedic’s position as a reliable supplier of high-quality products in the Nordics, we believe this agreement will accelerate access to our products for patients outside of Sweden. I look forward to collaborating closely with the team at Navamedic to contribute to improving the quality of life for people,” said Tony Brejke, Managing Director and owner of Impolin AB.

Navamedic will settle SEK 25 mill of the purchase price by way of issuing new shares to the seller through conversion of an account receivable to be issued by Navamedic to the seller at closing. The remaining portion of the purchase price will be settled in cash. In addition, the seller may be entitled to an additional consideration in the amount of SEK 5 mill if certain pre-agreed milestones for Impolin AB are satisfied by year-end 2022. The subscription price for the new shares shall be equal to the volume weighted average share price of the Company’s shares on the Oslo Stock Exchange during the period from 31 December 2021 to the closing date of the transaction. The consideration shares will be listed on the Oslo Stock Exchange and be subject to a lock-up period of 24 months from the closing date. The board of directors of Navamedic will issue the consideration shares pursuant to an authorization to issue new shares granted to it by the general meeting of the Company on 3 June 2021 or, if completion occurs after the expiry of such authorization, a new authorization to be approved by the Annual General Meeting of the Company.

The completion of the transaction is subject to Impolin AB amending one of its material agreements on terms and conditions satisfactory to Navamedic, in addition to certain customary conditions. It is expected that the transaction will be completed during Q2 2022.

Go to press release

Categories: News

Tags:

General Atlantic, Nautic Partners and The Vistria Group Announce Strategic Acquisition of PANTHERx Rare From Centene Corporation

General Atlantic

Investor consortium plans to partner with PANTHERx Rare to fuel its continued expansion as a leading rare and orphan focused specialty pharmacy

A leading investor consortium consisting of Nautic Partners, The Vistria Group and General Atlantic today announced it has signed a definitive agreement to acquire PANTHERx Rare (“PANTHERx” or “The Company”) from Centene Corporation (NYSE: CNC). The new partnership will focus on accelerating PANTHERx Rare’s continued growth as a premier and trusted pharmacy care delivery model for patients living with rare and orphan diseases.

“PANTHERx transforms lives by providing access solutions to people living with rare medical conditions,” said Jon Maschmeyer, Senior Partner and Co-Head of Healthcare at The Vistria Group. “Our investment was a collaborative effort to bring focus to an area that not only has been significantly underserved but also offers a wealth of opportunity to enhance the lives of patients.”

“We see a growing market need for a specialized pharmacy model to support rare and orphan disease patients in their healthcare journey and to meet the unique distribution demands of these life-enriching medicines,” said Justin Sunshine, Managing Director at General Atlantic.

PANTHERx has emerged as a pioneer of rare disease pharmacy, becoming the first rare-disease-certified specialty pharmacy and earning recognition for its culture, service levels and industry-leading growth. PANTHERx was recently awarded Specialty Pharmacy of the Year by the National Association of Specialty Pharmacy (NASP), earned the inaugural Accredited Distinction in Rare Diseases and Orphan Drugs from the Accreditation Commission for Health Care (ACHC), and is a five-time winner of the prestigious MMIT Patient Choice Award, including in 2022.

“PANTHERx is purpose-built to serve this patient population and help address the complexities of specialized care delivery,” said Chris Corey, Managing Director at Nautic Partners. “General AtlanticNautic Partners and The Vistria Group are pleased to partner together to support the long-term growth of PANTHERx, leveraging our collective expertise in scaling differentiated healthcare businesses and fueling further innovation.”

“PANTHERx is deeply committed to redefining and enhancing specialty pharmacy by anticipating the diverse needs of the patients we serve,” said Rob Snyder, CEO of PANTHERx Rare. “With the enhanced resources brought by The Vistria Group, General Atlantic and Nautic Partners, we’re confident in this investment’s potential to deliver innovative outcomes for patients suffering from rare and orphan diseases. We thank Centene for their support over the past year and a half and look forward to the future ahead.”

The transaction is subject to clearance under the Hart-Scott Rodino Act and satisfaction of other customary closing conditions. Following the close of the transaction, the three consortium participants will each hold equal ownership of PANTHERx.

About PANTHERx Rare

PANTHERx Rare is one of the largest and fastest growing rare pharmacies in the United States. PANTHERx transforms lives by delivering medicine breakthroughs, clinical excellence, and access solutions to people living with rare and devastating conditions. Although the overall incidence of rare diseases is as common as diabetes, less than 7% of the 7,000 known rare and devastating disorders have an FDA-approved therapy. Changes in federal policy and advances in science have led to a surge in FDA orphan drug approvals, providing tremendous hope to the rare disease community.

PANTHERx was recently awarded Specialty Pharmacy of the Year by the National Association of Specialty Pharmacy (NASP) and earned the inaugural Accredited Distinction in Rare Diseases and Orphan Drugs from the Accreditation Commission for Health Care (ACHC). PANTHERx is now a five-time winner of the prestigious MMIT Patient Choice Award, including the 2022 honor. PANTHERx is headquartered in Pittsburgh, Pennsylvania, licensed in all 50 states, and holds accreditations from URAC, NABP, and ACHC.

About General Atlantic

General Atlantic is a leading global growth equity firm with more than four decades of experience providing capital and strategic support for over 445 growth companies throughout its history. Established in 1980 to partner with visionary entrepreneurs and deliver lasting impact, the firm combines a collaborative global approach, sector specific expertise, a long-term investment horizon and a deep understanding of growth drivers to partner with great entrepreneurs and management teams to scale innovative businesses around the world. General Atlantic currently has over $84 billion in assets under management inclusive of all products as of December 31, 2021, and more than 215 investment professionals based in New York, Amsterdam, Beijing, Hong Kong, Jakarta, London, Mexico City, Mumbai, Munich, Palo Alto, São Paulo, Shanghai, Singapore, Stamford and Tel Aviv. For more information on General Atlantic, please visit the website: www.generalatlantic.com.

About Nautic Partners

Nautic is a middle-market private equity firm that focuses on three industries: healthcare, industrials, and services. Nautic has completed over 150 platform transactions throughout its 35-plus year history. Nautic‘s strategy is to partner with management teams to accelerate the growth trajectory of its portfolio companies via add-on acquisitions, targeted operating initiatives, and increased management team depth. For more information, please visit www.nautic.com.

About The Vistria Group

The Vistria Group is a Chicago-based next generation private investment firm that operates at the intersection of purpose and profit. The Vistria Group partners with middle-market businesses in Healthcare, Education and Financial Services that are passionate about growth and committed to the community. Its decision to invest in these areas is driven by its belief in companies producing scalable social value. The Vistria Group’s team is comprised of highly experienced operating partners and investment professionals with proven track records of working with management teams in building innovative, market-leading companies. For more information, please visit Vistria.com.

View original content:https://www.prnewswire.com/news-releases/general-atlantic-nautic-partners-and-the-vistria-group-announce-strategic-acquisition-of-pantherx-rare-from-centene-corporation-301541030.html

Media Contacts

Emily Japlon & Kate Huneke
General Atlanticmedia@generalatlantic.com

Allan Petersen
Nautic Partnersapetersen@nautic.com

Grace Cronin
The Vistria Groupgcronin@respublicagroup.com

Categories: News

Aquiline Announces Closing of Aquiline Technology Growth Fund II

Aquiline

Fund closed with more than $365 million in total commitments, exceeding its target of $300 million

NEW YORK and LONDON, May 4, 2022 /PRNewswire/ — Aquiline Capital Partners LLC (“Aquiline”), a private investment firm based in New York and London with $8.7 billion in assets under management, today announced the final closing of Aquiline Technology Growth Fund II (“ATG II” or the “Fund”). The Fund closed with more than $365 million in total commitments, exceeding its target of $300 million and nearly doubling the $189 million in total commitments raised for Aquiline Technology Growth’s (“ATG”) first fund.

Aquiline has raised the Fund from new and existing investors around the world and plans to continue ATG’s strategy of partnering with innovative early- and growth-stage technology companies across fintech, insuretech and related enterprise software and services. ATG has made 27 investments over two funds, investing across the financial services value chain in companies that use technology to enable functions including sales and distribution, automation of back-office functions, and product innovation.

“Today is yet another important milestone for Aquiline and a testament to the strong reputation we have developed with institutional investors around the world through our distinct investment approach,” said Jeff Greenberg, Chairman and CEO of Aquiline Capital Partners. “We are confident that our team is well-positioned to identify and invest in high-growth companies that can benefit from our robust network and deep industry expertise.”

“With this larger fund, ATG is now even better positioned to be a trusted partner to entrepreneurs who are building exciting, fast-growing businesses in our target markets across financial services,” said Max Chee, Head of Aquiline Technology Growth. “We are thrilled to have added some very important investors to our community and look forward to building and enhancing great companies together.”

“Our specialist focus has allowed us to target and invest in businesses that are solving real pain points in markets across financial services, such as insurance, that are not as well understood by the broader investment community and are earlier in their adoption of digital technologies than many other industries,” said Mike Cichowski, who leads ATG’s growth investing, which partners with boot-strapped companies requiring capital to accelerate growth.

About Aquiline Capital Partners Aquiline Capital Partners, founded in 2005, is a private investment firm based in New York and London investing in companies across financial services and technology, business services, and healthcare industries. The firm had $8.7 billion in assets under management as of March 31, 2022. For more information about Aquiline, its investment professionals, and its portfolio companies, please visit www.aquiline.com.

About Aquiline Technology Growth Aquiline Technology Growth (ATG) seeks to invest in early- and growth-stage technology companies that are bringing innovation to the insurance and financial services ecosystems. ATG is managed by Aquiline Capital Partners, a private investment firm based in New York and London investing in companies across financial services and technology, business services, and healthcare industries. The ATG team has experience in technology and financial services and is supported by its colleagues at Aquiline, strategic partners, and an active group of industry Executive Advisors. For more information on ATG, visit http://www.aquiline.com.

Categories: News

Tags:

BDC exits HKA

Bridgepoint

Bridgepoint Development Capital (‘BDC’) today announced the sale of HKA, a leading global consultancy in risk mitigation and dispute resolution, to PAI Partners.

Headquartered in the United Kingdom, HKA provides a comprehensive set of specialist offerings, including Expert, Claims and Advisory services for the capital projects and infrastructure sector. The Company has over 130 partners and more than 1,000 experts, consultants and advisors across 40+ offices in 18 countries.

HKA works with law firms, contractors, owners, operators, and other professional service providers across the breadth of the risk mitigation and dispute resolution market. The Company’s global portfolio includes some of the world’s largest and most prestigious commissions across a wide range of industries including industrial & manufacturing, power & utilities, resources and energy transition, transportation infrastructure, buildings, technology, financial services and government contracts.

Under Bridgepoint’s ownership, HKA has seen significant growth in its Claims, Dispute Resolution and Litigation Support business and successfully developed new service lines, including its offerings in Forensic Technical Services and Forensic Accounting and Commercial Damages. The Company significantly expanded its US operations through the transformational acquisition of The Kenrich Group in 2019, creating the region’s largest construction claims consultancy as well as significantly strengthening HKA’s global capabilities in forensics, commercial damages and government contract services. In 2020, the Company bolstered its Forensic Technical Services offering by acquiring Probyn Miers, the UK’s leading firm of Expert Architects in the field of Construction Dispute Avoidance and Resolution.

PAI will support HKA’s management team in delivering their future growth plans, including accelerating HKA’s growth through development into adjacent services and through selective and targeted M&A opportunities.

“HKA has been a successful investment for Bridgepoint. Working closely with management, together we built significant value by establishing a strong partnership culture, focusing on strategic geographic markets and undertaking selective M&A as well as a comprehensive operational improvement programme. These initiatives mean that the business is now well positioned for further growth under new ownership,” said Jeannele M’Bembath, Director at Bridgepoint Development Capital.

Renny Borhan, CEO of HKA, commented: “I am extremely proud of the successes the team at HKA has achieved to date, and I am very thankful for Bridgepoint’s support and expertise over the last five years. We are very excited to be partnering with PAI Partners in the next phase of our growth.”

Neil McIlroy, Partner at PAI Partners, added: “HKA is uniquely positioned in the large and fragmented risk mitigation and dispute resolution market, with attractive long term growth prospects. We look forward to supporting Renny and his talented team as they pursue organic and inorganic initiatives to deliver their ambitious business strategy.”

PAI Partners was advised by Rothschild & Co. and DC Advisory (M&A); Weil, Gotshal & Manges LLP (Legal); Alvarez & Marsal (Financial); and Bain & Company (Commercial).

Bridgepoint was advised by J.P. Morgan (M&A); Travers Smith (Legal); BDO (Financial); and OC&C (Commercial).

The transaction is subject to customary closing conditions.

Categories: News

Tags:

BDC exits HKA

Bridgepoint

Bridgepoint Development Capital (‘BDC’) today announced the sale of HKA, a leading global consultancy in risk mitigation and dispute resolution, to PAI Partners.

Headquartered in the United Kingdom, HKA provides a comprehensive set of specialist offerings, including Expert, Claims and Advisory services for the capital projects and infrastructure sector. The Company has over 130 partners and more than 1,000 experts, consultants and advisors across 40+ offices in 18 countries.

HKA works with law firms, contractors, owners, operators, and other professional service providers across the breadth of the risk mitigation and dispute resolution market. The Company’s global portfolio includes some of the world’s largest and most prestigious commissions across a wide range of industries including industrial & manufacturing, power & utilities, resources and energy transition, transportation infrastructure, buildings, technology, financial services and government contracts.

Under Bridgepoint’s ownership, HKA has seen significant growth in its Claims, Dispute Resolution and Litigation Support business and successfully developed new service lines, including its offerings in Forensic Technical Services and Forensic Accounting and Commercial Damages. The Company significantly expanded its US operations through the transformational acquisition of The Kenrich Group in 2019, creating the region’s largest construction claims consultancy as well as significantly strengthening HKA’s global capabilities in forensics, commercial damages and government contract services. In 2020, the Company bolstered its Forensic Technical Services offering by acquiring Probyn Miers, the UK’s leading firm of Expert Architects in the field of Construction Dispute Avoidance and Resolution.

PAI will support HKA’s management team in delivering their future growth plans, including accelerating HKA’s growth through development into adjacent services and through selective and targeted M&A opportunities.

“HKA has been a successful investment for Bridgepoint. Working closely with management, together we built significant value by establishing a strong partnership culture, focusing on strategic geographic markets and undertaking selective M&A as well as a comprehensive operational improvement programme. These initiatives mean that the business is now well positioned for further growth under new ownership,” said Jeannele M’Bembath, Director at Bridgepoint Development Capital.

Renny Borhan, CEO of HKA, commented: “I am extremely proud of the successes the team at HKA has achieved to date, and I am very thankful for Bridgepoint’s support and expertise over the last five years. We are very excited to be partnering with PAI Partners in the next phase of our growth.”

Neil McIlroy, Partner at PAI Partners, added: “HKA is uniquely positioned in the large and fragmented risk mitigation and dispute resolution market, with attractive long term growth prospects. We look forward to supporting Renny and his talented team as they pursue organic and inorganic initiatives to deliver their ambitious business strategy.”

PAI Partners was advised by Rothschild & Co. and DC Advisory (M&A); Weil, Gotshal & Manges LLP (Legal); Alvarez & Marsal (Financial); and Bain & Company (Commercial).

Bridgepoint was advised by J.P. Morgan (M&A); Travers Smith (Legal); BDO (Financial); and OC&C (Commercial).

The transaction is subject to customary closing conditions.

Categories: News

Tags:

Ferd acquires 33 percent of the diagnostics company Aidian

Nordstjernan

The Finnish company Aidian develops, manufactures and sells instruments and tests that are used in such fields as primary care to provide quick and accurate test results. Aidian’s range of tests addresses several global health problems, such as antimicrobial resistance (AMR), diabetes and colorectal cancer. Aidian has tests that are intended to reduce unnecessary prescriptions of antibiotics, which is a driver behind the growing threat from AMR and antibiotic-resistant bacteria.
“Finnish company Aidian has built up a leading, global position in point-of-care diagnostics. The company’s instruments and tests are a key part of meeting global health-related challenges. Together with the majority shareholder Nordstjernan we want to develop the company further, with the aim of continuing to build up a leading player in point-of-care diagnostics”, says Morten Borge, CEO of Ferd.
Earlier this year, the Swedish family-controlled investment company Nordstjernan announced that it had acquired 100 percent of the shares in Aidian. Ferd is now purchasing 33 percent of the shares, thus becoming a part-owner of Aidian.
“We are very pleased to have Ferd as a partner in Aidian’s further development and growth journey. Nordstjernan and Ferd share many similarities in that we are family-controlled companies that both apply a long-term approach to our investments. We both also see great potential in the healthcare sector”, says Peter Hofvenstam, CEO of Nordstjernan.
The parties have agreed not to disclose the conditions of the transaction.

Peter Hofvenstam
President and CEO
Nordstjernan AB
Questions will be answered by:
Stefan Stern, Head of Communications, Nordstjernan
Telephone: +46 70 636 74 17
E-mail: stefan.stern@nordstjernan.se
 
Nordstjernan is a family-controlled investment company whose business concept is to be an active owner that creates long-term value growth. More information about Nordstjernan can be found on www.nordstjernan.se.


Categories: News

Tags:

Advent International and GHL Hotels agree to form a partnership to accelerate GHL’s growth in Latin America

Advent International

BOGOTÁ, May 3, 2022 – Advent International (“Advent”), one of the largest and most experienced global private equity investors, and GHL Hotels (“GHL”), one of the largest third-party hotel operator in the region, part of GHL Group, today announced that they have agreed to enter into a partnership, whereby Advent will invest in GHL and support its expansion across Latin America.

The partnership will strengthen GHL’s financial position to accelerate growth through new operating contracts, additional investments in hotels and acquisitions of other third-party hotel operators.

Jorge Londoño, Co-Founder and CEO of GHL, said, “This investment from a world-class investor like Advent is a sign of confidence in our potential and an endorsement of our business model, track record and achievements. We have big expansion plans to consolidate our position as the largest Latin American player in the sector, and by partnering with Advent we are confident that we will achieve this goal.”

“We are excited to partner with GHL, a company that has achieved excellent growth and strong performance in a sector that shows great prospects in Colombia and the region,” said Mauricio Salgar, Managing Director of Advent International in Bogotá. “We look forward to working with GHL’s management team and supporting the company’s growth and consolidation in the region. As a seasoned investor in the hospitality sector, Advent will provide knowledge and expertise in an industry that is increasingly dominated by global players.”

GHL is the largest third-party hotel operator in the Andean region and Central America. It began operations in 1964 with five hotels in the south of Colombia. Fifty-six years later, GHL is one of the main authorized multi-brand operators in the region, operating 62 hotels in Colombia, Ecuador, Perú, Central America, Chile, and Argentina, with a portfolio of more than 7,000 rooms and 5,000 employees. The portfolio includes hotels operating under international brands such as Hyatt, Marriott, Radisson and Sonesta.

“In more developed markets, such as the United States, we’ve seen hotel operations shift to specialized third-party hotel operators rather than hotel chains or property owners,” added Salgar of Advent. “This trend is now expanding into other markets, including in Latin America, where GHL is a leading player and aspires to continue solidifying its position in the market.”

This investment follows Advent’s acquisition of a majority stake in Aimbridge Hospitality, the world’s leading third-party hotel management company, with approximately 1,500 properties in 20 countries and in 49 states of USA. Aimbridge operates a diverse portfolio of brands that includes 84 different lodging brands, in addition to the more than 82 independent boutique/lifestyle hotels they operate. During Advent’s investment, the company has significantly grown its hotel portfolio and in 2021 acquired Prisma Hotels, the largest hotel operator in Mexico with 42 hotels and more than 7,500 rooms across the country.

About GHL Hotels

GHL Hotels has more than 56 years of experience operating world-renowned brands such as Sheraton, Four Points by Sheraton, Sonesta, Hyatt and Radisson. Additionally, they have developed their own brands that include GHL Collection, GHL Relax and GHL Style.
With presence in 11 Latin American countries, from Guatemala to Chile, GHL Hotels offers solutions for accommodation, events, restaurants, and entertainment in each of the 62 properties they manage.

For more information, visit:
Website: www.//en.ghlhoteles.com/
LinkedIn: www.linkedin.com/company/ghlhoteles/

About Advent International Colombia

Advent International has been present in Colombia since 2011 and currently has 12 professionals dedicated to investing in the country. The team has invested more than US$1 billion in companies with relevant operations in Colombia such as LifeMiles, Alianza Fiduciaria, Alianza Valores, Grupo Biotoscana, GTM, Ocensa and most recently, Sophos Solutions.
.

About Advent International

Founded in 1984, Advent International is one of the largest and most experienced global private equity investors. The firm has invested in over 390 private equity investments across 41 countries, and as of December 31, 2021, had $88 billion in assets under management. With 15 offices in 12 countries, Advent has established a globally integrated team of over 265 private equity investment professionals across North America, Europe, Latin America and Asia. The firm focuses on investments in five core sectors, including business and financial services; health care; industrial; retail, consumer and leisure; and technology. For over 35 years, Advent has been dedicated to international investing and remains committed to partnering with management teams to deliver sustained revenue and earnings growth for its portfolio companies.

For more information, visit:
Website: www.adventinternational.com
LinkedIn: www.linkedin.com/company/advent-international

Categories: News

Tags: